Dyspnoea: a multidimensional and multidisciplinary approach
Standard
Dyspnoea: a multidimensional and multidisciplinary approach. / Laviolette, Louis; Laveneziana, Pierantonio; ERS Research Seminar Faculty.
in: EUR RESPIR J, Jahrgang 43, Nr. 6, 01.06.2014, S. 1750-62.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Dyspnoea: a multidimensional and multidisciplinary approach
AU - Laviolette, Louis
AU - Laveneziana, Pierantonio
AU - ERS Research Seminar Faculty
AU - Von Leupoldt, Andreas
N1 - ©ERS 2014.
PY - 2014/6/1
Y1 - 2014/6/1
N2 - Dyspnoea is a debilitating symptom that affects quality of life, exercise tolerance and mortality in various disease conditions/states. In patients with chronic obstructive pulmonary disease (COPD), it has been shown to be a better predictor of mortality than forced expiratory volume in 1 s. In patients with heart disease it is a better predictor of mortality than angina. Dyspnoea is also associated with decreased functional status and worse psychological health in older individuals living at home. It also contributes to the low adherence to exercise training programmes in sedentary adults and in COPD patients. The mechanisms of dyspnoea are still unclear. Recent studies have emphasised the multidimensional nature of dyspnoea in the sensory-perceptual (intensity and quality), affective distress and impact domains. The perception of dyspnoea involves a complex chain of events that depend on varying cortical integration of several afferent/efferent signals and coloured by affective processing. This review, which stems from the European Respiratory Society research symposium held in Paris, France in November 2012, aims to provide state-of-the-art advances on the multidimensional and multidisciplinary aspects of dyspnoea, by addressing three different themes: 1) the neurophysiology of dyspnoea, 2) exercise and dyspnoea, and 3) the clinical impact and management of dyspnoea.
AB - Dyspnoea is a debilitating symptom that affects quality of life, exercise tolerance and mortality in various disease conditions/states. In patients with chronic obstructive pulmonary disease (COPD), it has been shown to be a better predictor of mortality than forced expiratory volume in 1 s. In patients with heart disease it is a better predictor of mortality than angina. Dyspnoea is also associated with decreased functional status and worse psychological health in older individuals living at home. It also contributes to the low adherence to exercise training programmes in sedentary adults and in COPD patients. The mechanisms of dyspnoea are still unclear. Recent studies have emphasised the multidimensional nature of dyspnoea in the sensory-perceptual (intensity and quality), affective distress and impact domains. The perception of dyspnoea involves a complex chain of events that depend on varying cortical integration of several afferent/efferent signals and coloured by affective processing. This review, which stems from the European Respiratory Society research symposium held in Paris, France in November 2012, aims to provide state-of-the-art advances on the multidimensional and multidisciplinary aspects of dyspnoea, by addressing three different themes: 1) the neurophysiology of dyspnoea, 2) exercise and dyspnoea, and 3) the clinical impact and management of dyspnoea.
KW - Congresses as Topic
KW - Dyspnea
KW - Exercise
KW - Exercise Tolerance
KW - France
KW - Health Status
KW - Humans
KW - Pulmonary Disease, Chronic Obstructive
KW - Pulmonary Medicine
KW - Respiration
KW - Treatment Outcome
U2 - 10.1183/09031936.00092613
DO - 10.1183/09031936.00092613
M3 - SCORING: Journal article
C2 - 24525437
VL - 43
SP - 1750
EP - 1762
JO - EUR RESPIR J
JF - EUR RESPIR J
SN - 0903-1936
IS - 6
ER -